05/16/2024
9:56 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
4:00 PM | CNS Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
4:28 PM | CNS Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/07/2024
4:00 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2024
5:37 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
8:50 PM | Charles Faith L. (Reporting)
CNS Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:50 PM | Climaco John M (Reporting)
CNS Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/10/2024
8:51 PM | CNS Pharmaceuticals (Issuer)
Cockroft Bettina M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:51 PM | CNS Pharmaceuticals (Issuer)
Downs Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:52 PM | CNS Pharmaceuticals (Issuer)
Evans Carl Anthony (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:52 PM | CNS Pharmaceuticals (Issuer)
Gumulka Jerzy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:52 PM | CNS Pharmaceuticals (Issuer)
Keyes Jeffry R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:53 PM | CNS Pharmaceuticals (Issuer)
Mahery Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
6:40 PM | CNS Pharmaceuticals (Filer)
| Form DEF 14A | |
03/28/2024
4:27 PM | CNS Pharmaceuticals (Filer)
| Form PRE 14A | |
02/14/2024
1:25 PM | ARMISTICE CAPITAL, LLC (Filed by)
CNS Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/06/2024
9:26 AM | CNS Pharmaceuticals (Issuer)
Mahery Amy (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/06/2024
9:27 AM | Climaco John M (Reporting)
CNS Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
9:27 AM | CNS Pharmaceuticals (Issuer)
Downs Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
9:27 AM | CNS Pharmaceuticals (Issuer)
Evans Carl Anthony (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
9:28 AM | CNS Pharmaceuticals (Issuer)
Gumulka Jerzy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
9:28 AM | CNS Pharmaceuticals (Issuer)
Mahery Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:00 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
3:27 PM | CNS Pharmaceuticals (Filer)
| Form 424B4 | |
01/29/2024
11:15 PM | CNS Pharmaceuticals (Filer)
| Form EFFECT | |
01/23/2024
3:01 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/22/2024
5:02 AM | CNS Pharmaceuticals (Filer)
| Form S-1/A | |
01/10/2024
4:26 PM | CNS Pharmaceuticals (Filer)
| Form S-1/A | |
12/21/2023
8:15 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
7:36 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/08/2023
4:28 PM | CNS Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
11/30/2023
11:15 PM | CNS Pharmaceuticals (Filer)
| Form EFFECT | |
11/30/2023
4:20 PM | CNS Pharmaceuticals (Filer)
| Form 424B3 | |
11/21/2023
8:11 PM | CNS Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/20/2023
4:26 PM | CNS Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/15/2023
7:00 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2023
8:00 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2023
7:00 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/12/2023
5:00 PM | Andraczke Andrzej (Reporting)
CNS Pharmaceuticals (Issuer)
| Form 4/A | |
10/12/2023
5:00 PM | Charles Faith L. (Reporting)
CNS Pharmaceuticals (Issuer)
| Form 4/A | |
10/12/2023
5:00 PM | CNS Pharmaceuticals (Issuer)
Cockroft Bettina M. (Reporting)
| Form 4/A | |
[URGENT] DO NOT Touch These AI Stocks! (Ad) Artificial intelligence stocks are carrying the market.
One of them, Nvidia, recently became the seventh company ever to hit a $1 trillion market cap.
But is this AI rally over? Click here for our #1 AI Stock for 2024 and Beyond |
10/12/2023
5:01 PM | CNS Pharmaceuticals (Issuer)
Keyes Jeffry R. (Reporting)
| Form 4/A | |
10/12/2023
5:01 PM | CNS Pharmaceuticals (Issuer)
Evans Carl Anthony (Reporting)
| Form 4/A | |
10/12/2023
5:01 PM | CNS Pharmaceuticals (Issuer)
Gumulka Jerzy (Reporting)
| Form 4/A | |
09/25/2023
5:20 PM | Andraczke Andrzej (Reporting)
CNS Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2023
5:20 PM | Charles Faith L. (Reporting)
CNS Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2023
5:21 PM | CNS Pharmaceuticals (Issuer)
Cockroft Bettina M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2023
5:24 PM | CNS Pharmaceuticals (Issuer)
Evans Carl Anthony (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2023
5:26 PM | CNS Pharmaceuticals (Issuer)
Gumulka Jerzy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2023
5:27 PM | CNS Pharmaceuticals (Issuer)
Keyes Jeffry R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
6:51 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/23/2023
7:00 AM | CNS Pharmaceuticals (Issuer)
Downs Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
4:25 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2023
7:30 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
4:12 PM | CNS Pharmaceuticals (Filer)
| Form DEF 14A | |
08/14/2023
8:25 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
6:34 AM | CNS Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023
8:14 PM | CNS Pharmaceuticals (Issuer)
Cockroft Bettina M. (Reporting)
| Form 4/A | |
